1. HBW Insight
  2. >>Ingredients & Safety

FDA Solicits Protocol For Assessing Cosmetic Ingredient Aggregate Exposure Risks

 
• By Ryan Nelson

According to its May 16 notice, the agency intends to award the contract to NSF International. An FDA spokesperson said NSF already undertook related work for the agency in 2018 and has rendered similar services for the US Environmental Protection Agency.

FDA entrance sign 2016

NSF International likely will be tapped to develop a protocol for the US Food and Drug Administration that can be used to assess cosmetic ingredient aggregate exposure risks.

FDA posted a notice May 16 to the US Federal Business Opportunities website (fbo.gov), stating its intention to procure...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

Just One More Step Before The First Legal UK CBD Food Supplements

 
• By David Ridley

UK CBD food supplement applications from Chanelle McCoy, Cannaray Brands and the European Industrial Hemp Association pass FSA's safety assessment stage and are now out for consultation. After that, only government approval stands in their way, with five years exclusivity the icing on the cake.

German Quaternary Wastewater Treatment Cost Estimates ‘Not Realistic’

 
• By David Ridley

Updating wastewater treatment facilities in Germany will cost almost three times more than the German Association of Local Public Utilities (VKU) has predicted, according to a Pharma Deutschland analysis.

GSCF: ‘No One Size Fits All’ Solution To Tricky Sustainable Blister Pack Challenge

 
• By David Ridley

A series of research papers recently published by the Global Self-Care Federation indicate that industry will need to be pragmatic about alternatives to PVC in medicine blister packs.

EFSA: ‘A Dose Of Estragole Without A Harmful Effect Cannot Be Established’

 
• By David Ridley

Dietary supplements containing estragole may have to be removed from the European Union market due to carcinogenic risk, according to a draft scientific opinion from EFSA that is currently out for consultation.

More from HBW Insight

Opella Switches Cialis In Norway

 
• By David Ridley

Norway becomes the third European country to approve OTC sales of tadalafil. Cialis reseptfri will “soon be on shelves,” Opella says, with the launched being planned in partnership with Stada Arzneimittel.

Avista Adds To EU Consumer Health Portfolio With PK Benelux Deal

 
• By Tom Gallen

Private equity firm Avista attracted by PK Benelux' "leadership in innovation" in the Dutch vitamins, minerals and supplements market.

Citizen Petition Stirs Loper Bright Decision Into Convincing FDA To Allow 118 Health Claims

 
• By Malcolm Spicer

Alliance of Natural Health launches initiative to change FDA’s use of “significant scientific agreement” standard for allowing health claims with a citizen petition for approval of 118 nutrient-disease health claims.